Literature DB >> 34457731

Active Learning to Promote Early and Effective Physician Interaction with Pharmaceutical Industry Marketing Practices.

Elan Baskir1, Gagani Athauda2, Golsheed N Zeiarati2, Sanaz B Kashan1, Eduardo Camps-Romero1, Marin Gillis1.   

Abstract

BACKGROUND: Interactions with pharmaceutical companies influence physicians' prescribing behavior. Less than half of US family medicine residency programs have educational curricula addressing their influence. However, medical students have extensive exposure to pharmaceutical industry marketing during their early years of training. We developed a successful and required active learning curriculum for medical students during their first-year of medical school.
METHODOLOGY: A philosopher bioethicist lectured to first-year medical students on the ethical issues surrounding the interactions with pharmaceutical representatives and outlined the three principles approach to clinical ethics as presented in the American Board of Internal Medicine Physician Charter (2002). The lecture also described the eight physician types offered by Fugh-Berman et al. Students watched two fictitious physician-pharmaceutical representative interactions. To promote active learning, students were provided a 3 × 3 Bingo card with each physician type. The bioethicist facilitated a discussion addressing the interactions.
RESULTS: Two hundred twenty-nine first-year medical students participated in this required intervention. Fifty-two percent of first-year medical students had already interacted with pharmaceutical representatives. The session changed students' opinions of pharmaceutical representatives and their ability to identify strategies to mitigate their influence. Students articulated ethical issues involved in the interaction, techniques used by pharmaceutical representatives, and techniques that could be used by medical students or physicians. Ninety-one percent of students believed they could independently find reliable information about a drug.
CONCLUSION: The session was effective to start the conversation regarding the ethical issues involved with the interaction between medical students/physicians and pharmaceutical representatives in the first year of medical school. © International Association of Medical Science Educators 2020.

Entities:  

Keywords:  Ethics; First-year medical students; Medical education; Pharmaceutical industry

Year:  2020        PMID: 34457731      PMCID: PMC8368611          DOI: 10.1007/s40670-020-00943-y

Source DB:  PubMed          Journal:  Med Sci Educ        ISSN: 2156-8650


  20 in total

1.  Physicians and the pharmaceutical industry: is a gift ever just a gift?

Authors:  A Wazana
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

2.  An innovative approach to educating medical students about pharmaceutical promotion.

Authors:  M S Wilkes; J R Hoffman
Journal:  Acad Med       Date:  2001-12       Impact factor: 6.893

3.  Are sample medicines hurting the uninsured?

Authors:  John Zweifler; Susan Hughes; Sean Schafer; Bruno Garcia; Angela Grasser; Leticia Salazar
Journal:  J Am Board Fam Pract       Date:  2002 Sep-Oct

4.  Lunch with Lilly: who pays?

Authors:  Carson Strong
Journal:  Am J Bioeth       Date:  2003       Impact factor: 11.229

5.  All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.

Authors:  Dana Katz; Arthur L Caplan; Jon F Merz
Journal:  Am J Bioeth       Date:  2010-10       Impact factor: 11.229

6.  Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.

Authors:  James L Wofford; Christopher A Ohl
Journal:  BMC Med Educ       Date:  2005-02-08       Impact factor: 2.463

7.  Medical students' exposure to pharmaceutical industry marketing: a survey at one U.S. medical school.

Authors:  Melena Bellin; Susan McCarthy; Laurel Drevlow; Claus Pierach
Journal:  Acad Med       Date:  2004-11       Impact factor: 6.893

Review 8.  A systematic review of curricula on relationships between residents and the pharmaceutical industry.

Authors:  Brian T Montague; Auguste H Fortin; Julie Rosenbaum
Journal:  Med Educ       Date:  2008-03       Impact factor: 6.251

9.  Medical students' exposure to and attitudes about drug company interactions: a national survey.

Authors:  Frederick S Sierles; Amy C Brodkey; Lynn M Cleary; Frederick A McCurdy; Matthew Mintz; Julia Frank; D Joanne Lynn; Jason Chao; Bruce Z Morgenstern; William Shore; John L Woodard
Journal:  JAMA       Date:  2005-09-07       Impact factor: 56.272

Review 10.  Following the script: how drug reps make friends and influence doctors.

Authors:  Adriane Fugh-Berman; Shahram Ahari
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.